Viewing nowZymar 20 mg (Memantine Hydrochloride)
Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

MFDS item code 202500393 · Approved 2025.02.24 · Insurance code 649508570
Treatment of moderate to severe Alzheimer's disease
This medication is used for the treatment of moderate to severe Alzheimer's disease. It helps improve cognitive function decline and deterioration in daily living activities due to Alzheimer's disease. It assists in enhancing patients' memory and alleviating behavioral symptoms, thus improving quality of life. Through professional treatment, it is possible to slow the progression of the disease and manage symptoms.
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only if a caregiver is available to regularly check that the patient is taking the medication. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this drug and the patient's tolerability of treatment should be reassessed regularly. This drug is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, reach the maintenance dose by increasing the dose by 5mg per week over the first 3 weeks as follows. Week 1 (Days 1–7): Administer 5mg daily for 7 days. Week 2 (Days 8–14): Administer 10mg daily for 7 days. Week 3 (Days 15–21): Administer 15mg daily for 7 days. From Week 4 onward, administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Older adults Based on clinical data, the recommended dose for patients aged 65 years and older is 20mg daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-titration regimen. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.
This medicine should never be administered to patients with an allergy to its components. It should also not be used in patients with severely impaired liver function or extremely poor kidney function. Patients with epilepsy or those who have a history of seizures, as well as those who are predisposed to epilepsy, should use this medication with special caution. Taking this medicine in combination with other drugs that have similar effects may increase central nervous system side effects, so it should be avoided. Patients with factors that change the acidity (pH) of urine should carefully monitor their kidney function when using this medication. In patients with heart-related diseases or uncontrolled high blood pressure, the safety of this medication has not been sufficiently confirmed, so it should be administered with caution. While taking this medicine, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, so if symptoms worsen, medical consultation is necessary. This medication may interact with various drugs, so it is crucial to inform your doctor or pharmacist if you are taking other medications. Pregnant women or women who may become pregnant should consult a doctor before taking this medication, and it is advisable to discontinue breastfeeding if nursing. The safety and efficacy of this drug have not been sufficiently established in children or adolescents under 18 years of age, so it is best not to use it in this population. In case of overdose, central nervous system symptoms as well as gastrointestinal symptoms may occur, so strict adherence to the prescribed dosage is necessary, and in case of overdose, immediate medical attention should be sought. This medication can affect the patient's reaction speed and concentration, thus caution is needed when driving or operating machinery. It should be kept in a safe place out of the reach of children, and transferring the medication to another container may not be good for quality maintenance, so it should be avoided.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. The storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius.
Pink oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMemantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.